Gallacher Capital Management LLC Cassava Sciences Inc Transaction History
Gallacher Capital Management LLC
- $202 Billion
- Q4 2024
A detailed history of Gallacher Capital Management LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Gallacher Capital Management LLC holds 19,800 shares of SAVA stock, worth $45,738. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,800
Previous 23,400
15.38%
Holding current value
$45,738
Previous $336 Million
99.94%
% of portfolio
0.0%
Previous 0.15%
Shares
9 transactions
Others Institutions Holding SAVA
# of Institutions
189Shares Held
13.4MCall Options Held
2.96MPut Options Held
6.55M-
Black Rock Inc. New York, NY3.22MShares$7.44 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.51MShares$5.81 Million0.0% of portfolio
-
State Street Corp Boston, MA1.16MShares$2.69 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.01MShares$2.33 Million0.0% of portfolio
-
Morgan Stanley New York, NY520KShares$1.2 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $92.6M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...